Uncategorised - European Medical Journal

Talking to Emma Clayton

Emma Clayton, CEO, Grey Bear Consultancy, talks about the journey to starting her own agency, pharma communications in the COVID-19 era, and empowering women to succeed in the workplace.

Keeping Frankenstein’s Monster at Bay

I am not a fatalist, I do not believe things happen for a reason, but I do believe we can find reason in the things that happen…

Editor's Pick: Targeting Raised von Willebrand Factor Levels in Liver Diseases: Opening Up Newer Therapeutic Avenues

The most commonly inherited bleeding disorder, von Willebrand disease, is caused by the deficiency of von Willebrand factor (VWF)…

Cancer Care Seeing Dramatic Changes in Light of COVID-19

Cancer Care Seeing Dramatic Changes in Light of COVID-19

SIGNIFICANT changes in cancer care are occurring and expected to continue for the duration of the COVID-19 pandemic, a message delivered in a recently…

Age and sex

Age and Sex Shown to Not Influence Overall Survival in Metastatic Renal Cell Carcinoma

PATIENT counselling is more important than ever for those with cancer, especially considering the burgeoning number of treatments available…

ICDS Interview with Professor Abe Fingerhut

We sat down with Prof Abe Fingerhut at the ICDS to discuss his long and illustrious career in colorectal surgery.

EMJ Podcast: The Frontline of Coronavirus

In this special episode, a chat with an NHS doctor on the frontline of COVID-19 and a patient who has just recovered from the virus.

In Vitro Fertilisation and Covid-19: Insights From An Embryologist

We interviewed clinical embryologist Prof George Anifandis, who discussed some of the key advances and challenges in reproductive medicine and delineated…

AACR Virtual Annual Meeting I

AACR Virtual Annual Meeting I

The AACR Virtual Annual Meeting I will take place April 27-28. This meeting, which will be the first of two virtual meetings, is FREE and will feature an…

Talking to Pierre van Weperen

Pierre van Weperen, Chief Commercial Officer, Grow Biotech, discusses the potential of medicinal cannabis and big pharma vs start-ups.